Literature DB >> 29318978

Cognitive Impact of Cerebellar Damage: Is There a Future for Cognitive Rehabilitation?

Kim van Dun1, Frank V Overwalle2, Mario Manto3,4,5, Peter Marien1,6.   

Abstract

BACKGROUND &
OBJECTIVE: During the past 3 decades, numerous neurophysiological, neuroimaging, experimental and clinical studies have evidenced a crucial role for the cerebellum in cognitive, affective and behavioral functions. As a result of the acknowledged modulatory role of the cerebellum upon remote structures such as the cerebral cortex, cerebellar injury may give rise to a constellation of behavioral, affective and cognitive symptoms (Schmahmann's Syndrome). In sharp contrast to the wide range of therapeutic interventions to treat cognitive and affective disorders following cerebral cortical lesions and despite the consequences of Schmahmann's syndrome upon daily life activities, the literature is surprisingly only scantly documented with studies investigating the impact of cognitive therapies on cerebellar induced cognitive and affective disorders. This survey aims to present an overview of the therapeutic interventions available in the literature as a possible treatment for Schmahmann's Syndrome after cerebellar injury, after posterior fossa surgery in children, and in children with neurodevelopmental disorders. Although systematical studies are clearly warranted, available evidence suggests that cerebellar-induced cognitive and affective disorders should be treated in a specific way. Approaches where the patients are explicitly made aware of their deficits and are considered to act as an "external cerebellum" are the most promising.
CONCLUSION: The study of the anatomical connectivity of the cerebellar microcomplexes involved in cognitive/affective deficits is likely to play a major-role in the future. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Cerebellum; Schmahmann’s syndrome; ataxias; cognition; enhancement; rehabilitation.

Mesh:

Year:  2018        PMID: 29318978     DOI: 10.2174/1871527317666180110125043

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  5 in total

Review 1.  Cerebellar Cortex as a Therapeutic Target for Neurostimulation.

Authors:  Kim van Dun; Hiroshi Mitoma; Mario Manto
Journal:  Cerebellum       Date:  2018-12       Impact factor: 3.847

2.  Cerebellum and Neurorehabilitation in Emotion with a Focus on Neuromodulation.

Authors:  Kim van Dun; Mario Manto; Raf Meesen
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

Review 3.  Recent Advances in the Treatment of Cerebellar Disorders.

Authors:  Hiroshi Mitoma; Mario Manto; Jordi Gandini
Journal:  Brain Sci       Date:  2019-12-23

Review 4.  The Cerebellar Cognitive Affective/Schmahmann Syndrome: a Task Force Paper.

Authors:  Georgios P D Argyropoulos; Kim van Dun; Michael Adamaszek; Maria Leggio; Mario Manto; Marcella Masciullo; Marco Molinari; Catherine J Stoodley; Frank Van Overwalle; Richard B Ivry; Jeremy D Schmahmann
Journal:  Cerebellum       Date:  2020-02       Impact factor: 3.847

Review 5.  Consensus Paper. Cerebellar Reserve: From Cerebellar Physiology to Cerebellar Disorders.

Authors:  H Mitoma; A Buffo; F Gelfo; X Guell; E Fucà; S Kakei; J Lee; M Manto; L Petrosini; A G Shaikh; J D Schmahmann
Journal:  Cerebellum       Date:  2020-02       Impact factor: 3.847

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.